Предменструальный синдром: обзор литературы


Цитировать

Полный текст

Аннотация

Предменструальный синдром определяется как сочетание физических и психических симптомов, которые оказывают значимое влияние на качество жизни женщины и развиваются во II фазу менструального цикла. Многим пациенткам не установлен диагноз, в связи с чем не проводится патогенетического лечения, хотя данные жалобы могут нарушать повседневную жизнь больных и отношения с окружающими. В статье представлен обзор литературы и исследований, в которых проводилась оценка эффективности различных вариантов лечения (антидепрессанты, гормональная терапия, модификация образа жизни и растительные препараты).

Об авторах

Елена Николаевна Андреева

ФГБУ «НМИЦ эндокринологии»; ФГБОУ ВО «МГМСУ им. А.И. Евдокимова»

Email: endogin@mail.ru
д-р мед. наук, проф. каф. эндокринологии, зам. дир., дир. Института репродуктивной медицины, проф. каф. репродуктивной медицины и хирургии Moscow, Russia

Юлия Сергеевна Абсатарова

ФГБУ «НМИЦ эндокринологии»

Email: korsil2008@yandex.ru
науч. сотр. лечебно-диагностического отд-ния эндокринной гинекологии Moscow, Russia

Список литературы

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed). Arlington VA: 2013. American Psychiatric Publishing.
  2. Hartlage S, Freels S, Gotman N, Yonkers K. Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets. Arch Gen Psychiatry 2012; 69: 300-5. doi: 10.1001/archgenpsychiatry.2011.1368
  3. Вольфф М. Гинекологическая эндокринология и репродуктивная медицина. Пер. с нем. под общ. ред. Е.Н.Андреевой. М.: МЕДпресс-информ, 2017.
  4. Appleton S.M. Premenstrual Syndrome: Evidence-based Evaluation and Treatment. Clin Obstet Gynecol 2018; 61 (1): 52-61. doi: 10.1097/GRF.0000000000000339
  5. Heinemann L.A, Mihn T.D, Heinemann K et al. Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities. Health Care Women Int 2012; 33: 109-24. doi: 10.1080/07399332.2011.610530
  6. Chocano-Bedoya P.O, Manson J.E, Hankinson S.E et al. Dietary B vitamin intake and incident premenstrual syndrome. Am J Clin Nutr 2011; 93 (5): 1080-6. doi: 10.3945/ajcn.110.009530
  7. Hashemi S, Ramezani Tehrani F, Mohammadi N et al. Comparison of Metabolic and Hormonal Profiles of Women With and Without Premenstrual Syndrome: A Community Based Cross-Sectional Study. Int J Endocrinol Metab 2016; 14: e28422. doi: 10.5812/ijem.28422
  8. Bertone-Johnson E, Hankinson S, Willett W et al. Adiposity and the development of premenstrual syndrome. J Womens Health (Larchmt) 2010; 19: 1955-62. doi: 10.1089/jwh.2010.2128
  9. Perkonigg A, Yonkers K, Pfister H et al. Risk factors for premenstrual dysphoric disorder in a community sample of young women: The role of traumatic events and posttraumatic stress disorder. J Clin Psychiatry 2004; 65: 1314-22.
  10. Graze K, Nee J, Endicott J. Premenstrual depression predicts future major depressive disorder. Acta Psychiatr Scand 1990; 81: 201-5.
  11. Kendler K, Silberg J, Neale M et al. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study. Psychol Med 1992; 22: 85-100.
  12. Schmidt P, Martinez P, Nieman L et al. Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels. Am J Psychiatry 2017: appiajp201716101113. doi: 10.1176/appi.ajp.2017.16101113
  13. Bixo M, Ekberg K, Poromaa I.S et al. Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial. Psychoneuroendocrinology 2017; 80: 46-55. doi: 10.1016/j.psyneuen.2017.02.031
  14. Gracia C, Freeman E, Sammel M et al. Allopregnanolone levels before and after selective serotonin reuptake inhibitor treatment of premenstrual symptoms. J Clin Psychopharmacol 2009; 29: 403-5. doi: 10.1097/JCP.0b013e3181ad8825
  15. Eriksson E. SSRIs probably counteract premenstrual syndrome by inhibiting the serotonin transporter. J Psychopharmacol 2014; 28: 173-4. doi: 10.1177/0269881113512910
  16. Hiroi R, Mcdevitt R, Neumaier J.F. Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field. Biol Psychiatry 2006; 60: 288-95.
  17. Bertone-Johnson E.R, Whitcomb B.W, Rich-Edwards J.W et al. Premenstrual Syndrome and Subsequent Risk of Hypertension in a Prospective Study. Am J Epidemiol 2015; 182 (12): 1000-9. doi: 10.1093/aje/kwv159
  18. Bertone-Johnson E.R, Houghton S.C, Whitcomb B.W et al. Association of Premenstrual Syndrome with Blood Pressure in Young Adult Women. J Womens Health (Larchmt) 2016; 25 (11): 1122-8.
  19. Liu R, Mi B, Zhao Y et al. Effect of B Vitamins from Diet on Hypertension. Arch Med Res 2017; 48 (2): 187-94. doi: 10.1016/j.arcmed.2017.03.011
  20. Bender A, Hagan K.E, Kingston N. The association of folate and depression: A meta-analysis. J Psychiatr Res 2017; 95: 9-18. doi: 10.1016/j.jpsychires.2017.07.019
  21. Briguglio M, Dell'Osso B, Panzica G et al. Dietary Neurotransmitters: A Narrative Review on Current Knowledge. Nutrients 2018; 10 (5). pii: E591. doi: 10.3390/nu10050591
  22. Isgin-Atici K, Buyuktuncer Z, Akgül S, Kanbur N. Adolescents with premenstrual syndrome: not only what you eat but also how you eat matters! J Pediatr Endocrinol Metab 2018; 31 (11): 1231-9. doi: 10.1515/jpem-2018-0125
  23. Farasati N, Siassi F, Koohdani F et al. Western dietary pattern is related to premenstrual syndrome: a case-control study. Br J Nutr 2015; 114: 2016-21. doi: 10.1017/S0007114515003943
  24. Endicott J, Nee J, Harrison W. Daily record of severity of problems (DRSP): reliability and validity. Arch Womens Ment Health 2006; 9: 41-9.
  25. Daley A. Exercise and premenstrual symptomatology: a comprehensive review. J Womens Health (Larchmt) 2009; 18: 895-9. doi: 10.1089/jwh.2008.1098
  26. Green L, O' Brien P, Panay N, Craig M. Gynaecologists RCOOA. Management of premenstrual symptoms. Br J Obst Gynaecol 2016; 124: e73-e105.
  27. Hunter M, Ussher J, Browne S et al. A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder. J Psychosom Obstet Gynaecol 2002; 23: 193-9.
  28. Whelan A.M, Jurgens T.M, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol 2009; 16: e407-e429.
  29. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 2001; 322: 134-7.
  30. Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment ofpremenstrual dysphoric disorder. Hum Psychopharmacol 2003; 18: 191-5.
  31. Marjoribanks J, Brown J, O’Brien P.M, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2013; 6: CD 001396. doi: 10.1002/14651858. CD001396.pub3
  32. Freeman E.W, Rickels K, Yonkers K.A et al. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol 2001; 98 (pt 1): 737-44.
  33. Nevatte T, O’Brien P.M, Backstrom T et al.; Consensus Group of the International Society for Premenstrual Disorders. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health 2013; 16: 279-91. doi: 10.1007/s00737-013-0346-y
  34. Hunter M.S, Ussher J.M, Browne S.J et al. A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder. J Psychosom Obstet Gynaecol 2002; 23: 193-9.
  35. Joffe H, Cohen L.S, Harlow B.L. Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. Am J Obstet Gynecol 2003; 189: 1523-30.
  36. Pearlstein T.B, Bachmann G.A, Zacur H.A, Yonkers K.A. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 2005; 72: 414-21.
  37. Lopez L.M, Kaptein A.A, Helmerhorst F.M. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 2012; 2: CD006586. doi: 10.1002/14651858.CD006586.pub4
  38. Yonkers K.A, Simoni M.K. Premenstrual disorders. Am J Obstet Gynecol 2018; 218 (1): 68-74. doi: 10.1016/j.ajog.2017.05.045
  39. Giribela C.R, Consolim-Colombo F.M, Nisenbaum M.G et al. Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women. Gynecol Endocrinol 2015; 31 (11): 912-5. doi: 10.3109/09513590.2015.1062860
  40. Dinger J, Bardenheuer K, Heinemann K. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception 2014; 89: 253-63. doi: 10.1016/j.contraception.2014.01.023
  41. Wang M, Hammarbäck S, Lindhe B.A., Bäckström T. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Acta Obstet Gynecol Scand 1995; 74: 803-8.
  42. Brown C.S, Ling F.W, Andersen R.N et al. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet Gynecol 1994; 84: 779-86.
  43. Cronje W.H, Vashisht A, Studd J.W. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 2004; 19: 2152-5.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО "Консилиум Медикум", 2019

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).